Results of a prospective phase 2 study of pazopanib in patients with advanced intermediate-grade or high-grade liposarcoma.
Cancer
; 123(23): 4640-4647, 2017 Dec 01.
Article
in En
| MEDLINE
| ID: mdl-28832986
Full text:
1
Collection:
01-internacional
Health context:
3_ND
/
4_TD
Database:
MEDLINE
Main subject:
Pyrimidines
/
Sulfonamides
/
Angiogenesis Inhibitors
/
Liposarcoma
Type of study:
Clinical_trials
/
Observational_studies
/
Prognostic_studies
Limits:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Cancer
Year:
2017
Document type:
Article